PHARMACOLOGY OF NADOLOL (SQ 11725), A BETA-ADRENERGIC ANTAGONIST LACKING DIRECT MYOCARDIAL DEPRESSION

被引：115

作者：

LEE, RJ ^{[1
]}

EVANS, DB ^{[1
]}

BAKY, SH ^{[1
]}

LAFFAN, RJ ^{[1
]}

机构：

[1] SQUIBB INST MED RES, PRINCETON, NJ 08540 USA

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1975年 / 33卷 / 02期

关键词：

D O I：

10.1016/0014-2999(75)90182-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：371 / 382

页数：12

共 24 条

[1] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].

ARUNLAKSHANA, O ;

SCHILD, HO .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58

[2]

BLACK JW, 1964, LANCET, V1, P1081

[3] EVALUATION OF CARDIAC EFFECTS OF SEVERAL BETA ADRENERGIC BLOCKING AGENTS [J].

BLINKS, JR .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1967, 139 (A3) :673-&

[4] METABOLISM OF PROPRANOLOL (INDERAL) A POTENT SPECIFIC BETA-ADRENERGIC RECEPTOR BLOCKING AGENT [J].

BOND, PA .

NATURE, 1967, 213 (5077) :721-&

[5] PROPRANOLOL INHIBITION OF RENIN SECRETION - SPECIFIC APPROACH TO DIAGNOSIS AND TREATMENT OF RENIN-DEPENDENT HYPERTENSIVE DISEASES [J].

BUHLER, FR ;

BRUNNER, HR ;

BAER, L ;

VAUGHAN, ED ;

LARAGH, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (24) :1209-+

[6]

ELIASH S, 1971, BRIT J PHARMACOL, V43, P287

[7]

FITZ GERALD JD, 1969, CLIN PHARMACOL THER, V10, P292

[8]

GIBSON JK, 1974, PHARMACOLOGIST, V16, P201

[9]

HANSSON L, 1973, ACTA MED SCAND, P1

[10]

JEWITT DE, 1969, LANCET, V1, P635

← 1 2 3 →